Eiger BioPharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Eiger BioPharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $683K, a 62.9% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $5.01M, a 39.8% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.01M, a 39.8% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.32M, a 5.27% increase from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.9M, a 32.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.01M -$3.31M -39.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-08
2022 $8.32M +$416K +5.27% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-08
2021 $7.9M +$1.93M +32.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $5.97M +$294K +5.18% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-17
2019 $5.68M +$672K +13.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $5.01M +$764K +18% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 $4.24M +$1.05M +33% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-13
2016 $3.19M +$2.96M +1305% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $227K +$200K +741% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 $27K -$33.7K -55.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-23
2013 $60.7K -$237K -79.6% Jan 1, 2013 Dec 31, 2013 8-K/A 2016-06-17
2012 $298K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.